A 2026 case report described valproate 800 mg/day improving agitation in residual-phase treatment-resistant schizophrenia but being followed by hypoglycemia and pancytopenia; after discontinuation, lithium 600 mg/day at 0.8 mEq/L was associated with BPRS improvement from 80 to 64.1 The calibrated read is mixed: valproate looked behaviorally useful in 1 patient, but the safety signal was …
For two decades, headlines have linked autism to maternal obesity, depression, anxiety, gestational diabetes, infection, autoimmune disease, and antidepressant use. The studies behind those headlines are well-replicated registry associations. A new design from the Aarhus University iPSYCH group offers the most careful answer yet to what they mean for an individual pregnancy. Most “maternal X …
Depakote (divalproex sodium) is a medication regularly prescribed for the management of epilepsy, bipolar disorder, and migraine headaches. Other medical conditions for which Depakote is occasionally utilized as a complementary (i.e. adjunct) therapy include: AIDS, cancer, dopamine dysregulation syndrome (associated with Parkinson’s disease), schizophrenia. Most who are familiar with this drug understand that Depakote (divalproex …